Holdings
Commodore Capital LP
As of Sep 30, 2026, Commodore Capital LP reported 31 positions worth US$1.04B. Largest: Relay Therapeutics, Inc., Enliven Therapeutics, Inc. and Alto Neuroscience, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Relay Therapeutics, Inc. | 12M | US$217M | no change | Sep 30, 2026 |
| Enliven Therapeutics, Inc. | 3.27M | US$150M | no change | Sep 30, 2026 |
| Alto Neuroscience, Inc. | 2.72M | US$69.5M | no change | Sep 30, 2026 |
| Spyre Therapeutics, Inc. | 700K | US$62.3M | −147K | Sep 30, 2026 |
| Amylyx Pharmaceuticals, Inc. | 2M | US$58.2M | −3.65M | Sep 30, 2026 |
| LB Pharmaceuticals Inc | 1.28M | US$49.2M | −218K | Sep 30, 2026 |
| Cogent Biosciences, Inc. | 1.26M | US$40.5M | −1.78M | Sep 30, 2026 |
| Tyra Biosciences, Inc. | 1.73M | US$37.7M | −150K | Sep 30, 2026 |
| Celldex Therapeutics, Inc. | 1M | US$32.4M | −350K | Sep 30, 2026 |
| Surrozen, Inc. | 885K | US$28.5M | new | Sep 30, 2026 |